Project Details
| Short title | CIBI130A101 |
|---|---|
| Status | Active |
| Effective start/end date | 8/11/23 → 31/08/28 |
CTU: A Phase 1/2, Multicenter, Open-label Study of IBI130 in Subjects with Unresectable, Locally Advanced or Metastatic Solid Tumors
- Park, John (Primary Chief Investigator)
- Contacos, Christine (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
Project: Research